If You Invested $2,000 in Moderna Stock in 2019, This Is How Much You Would Have Today

Moderna (NASDAQ: MRNA) is one of the hottest biotechs on the market thanks to its rapid development of a functional coronavirus vaccine. Fueled by astronomically high predictions of its vaccine revenue, the stock continues to ascend higher and higher.

If you're like me, you're just a little bit bitter that you missed your chance to capture these stellar gains by investing early. But we can use these regrets to become stronger investors -- figuring out when we should have bought in, and calculating how much we could have made, can help us make better choices next time. Let's start by evaluating when the company might have shown up on our radar for the first time.

Image source: Getty Images.

Source Fool.com